Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC
- PMID: 36587812
- DOI: 10.1016/j.phrs.2022.106641
Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC
Abstract
Treatment of acute ischemic stroke with the recombinant tissue plasminogen activator (rtPA) is associated with increased blood-brain barrier (BBB) disruption and hemorrhagic transformation. Remote ischemic conditioning (RIC) has demonstrated neuroprotective effects against acute ischemic stroke. However, whether and how RIC regulates rtPA-associated BBB disruption remains unclear. Here, a rodent model of thromboembolic stroke followed by rtPA thrombolysis at different time points was performed with or without RIC. Brain infarction, neurological outcomes, BBB permeability, and intracerebral hemorrhage were assessed. The platelet-derived growth factor CC (PDGF-CC)/PDGFRα pathway in the brain tissue, PDGF-CC levels in the skeletal muscle and peripheral blood were also measured. Furthermore, impact of RIC on serum PDGF-CC levels were measured in healthy subjects and AIS patients. Our results showed that RIC substantially reduced BBB injury, intracerebral hemorrhage, cerebral infarction, and neurological deficits after stroke, even when rtPA was administrated in a delayed therapeutic time window. Mechanistically, RIC significantly decreased PDGFRα activation in ischemic brain tissue and reduced blood PDGF-CC levels, which partially resulted from PDGF-CC reduction in the skeletal muscle of RIC-applied hindlimbs and platelets. Intravenous or intraventricular recombinant PDGF-CC supplementation abolished RIC protective effects on BBB integrity. Moreover, similar changes of PDGF-CC in serum by RIC were also observed in healthy humans and acute ischemic stroke patients. Together, our study demonstrates that RIC can attenuate rtPA-aggravated BBB disruption after ischemic stroke via reducing the PDGF-CC/PDGFRα pathway and thus supports RIC as a potential approach for BBB disruption prevention or treatment following thrombolysis.
Keywords: Acute ischemic stroke; Blood-brain barrier; PDGF-CC; Remote ischemic conditioning; Thromboembolic stroke; rtPA.
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Conflict of interest The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.Acta Neuropathol. 2017 Oct;134(4):585-604. doi: 10.1007/s00401-017-1749-z. Epub 2017 Jul 19. Acta Neuropathol. 2017. PMID: 28725968 Free PMC article.
-
Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.Biomed Res Int. 2018 Apr 22;2018:8943210. doi: 10.1155/2018/8943210. eCollection 2018. Biomed Res Int. 2018. PMID: 29850586 Free PMC article.
-
Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.Mol Neurobiol. 2019 Sep;56(9):6521-6538. doi: 10.1007/s12035-019-1539-9. Epub 2019 Mar 9. Mol Neurobiol. 2019. PMID: 30852795
-
Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?J Cereb Blood Flow Metab. 2014 Aug;34(8):1283-96. doi: 10.1038/jcbfm.2014.99. Epub 2014 Jun 4. J Cereb Blood Flow Metab. 2014. PMID: 24896566 Free PMC article. Review.
-
Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.Pharmacol Ther. 2016 Nov;167:108-119. doi: 10.1016/j.pharmthera.2016.07.016. Epub 2016 Aug 12. Pharmacol Ther. 2016. PMID: 27524729 Free PMC article. Review.
Cited by
-
Exosomes: the next-generation therapeutic platform for ischemic stroke.Neural Regen Res. 2025 May 1;20(5):1221-1235. doi: 10.4103/NRR.NRR-D-23-02051. Epub 2024 May 13. Neural Regen Res. 2025. PMID: 39075892 Free PMC article.
-
Endothelial Dysfunctions in Blood-Brain Barrier Breakdown in Alzheimer's Disease: From Mechanisms to Potential Therapies.CNS Neurosci Ther. 2024 Nov;30(11):e70079. doi: 10.1111/cns.70079. CNS Neurosci Ther. 2024. PMID: 39548663 Free PMC article. Review.
-
The role of platelets in the blood-brain barrier during brain pathology.Front Cell Neurosci. 2024 Jan 8;17:1298314. doi: 10.3389/fncel.2023.1298314. eCollection 2023. Front Cell Neurosci. 2024. PMID: 38259501 Free PMC article. Review.
-
The factors affecting the development of medicinal plants from a value chain perspective.Planta. 2024 Mar 31;259(5):108. doi: 10.1007/s00425-024-04380-8. Planta. 2024. PMID: 38555562 Review.
-
Beyond Pharmacology: The Biological Mechanisms of Remote Ischemic Conditioning in Cerebrovascular Disease.Biomolecules. 2024 Nov 5;14(11):1408. doi: 10.3390/biom14111408. Biomolecules. 2024. PMID: 39595584 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical